CVR Medical Corp V.CVM.H

Alternate Symbol(s): CRRVF

Healthcare Biotechnology

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.

TSXV:CVM.H - Post by User

CVR Medical Corp

Bullboard Posts

Comment by Nastroon Feb 28, 2019 10:21am

45 Views

Post# 29422586

RE:RE:RE:RE:RE:Re: Time Line

The figure 31 relates to the number of de novo applications that were approved in 2017. The time to approval on average is 133 days from the date of submission.

slide 16 is a new slide as is 17, 25, 26, 27 & 28 so there is a fair bit of new material here. Slide 27 is interesting as it looks like they are evaluating 2 different revenue models, the first where they lease the device and charge a lower price for the consumables and the second where they give the device to the doctors for ‘free’ but charge double the price for the consumables. I guess they may decide to go down path 2 if they think it will lead to a faster adoption rate but yet to be determined.

the valuation comparison on page 28 is very interesting as I have looked at Helius in the past. It’s 7.5x greater market cap and also pre-revenue. I didn’t invest as I thought it very much a niche area rather than mass market like CVR.

Bullboard Posts

The top 10 Canadian medical stocks